Hawkins James B's Form 4 filing
Iradimed Corp (IRMD) · filed Aug 11, 2021
- Accession no.
- 0000898432-21-000601
- Filed
- Aug 11, 2021
- Trade date
- Aug 9-11, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $621.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hawkins James BCIK 0000898243 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2021 | Common Stock | AGrant or awardAcquired | +4,609 | $1.29F1 | +$5,945.61 | 21,877 | Direct | |
| Aug 9, 2021 | Common Stock | SSaleDisposed | −4,609 | $35.83F2 | −$165,140.47 | 17,268 | Direct | |
| Aug 10, 2021 | Common Stock | AGrant or awardAcquired | +5,000 | $1.29F1 | +$6,450 | 22,268 | Direct | |
| Aug 10, 2021 | Common Stock | SSaleDisposed | −5,000 | $35.72F3 | −$178,600 | 17,268 | Direct | |
| Aug 11, 2021 | Common Stock | AGrant or awardAcquired | +7,891 | $1.29F1 | +$10,179.39 | 25,159 | Direct | |
| Aug 11, 2021 | Common Stock | SSaleDisposed | −7,891 | $35.20F4 | −$277,763.2 | 17,268 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2021 | Common Stock | MOption exerciseDisposed | −4,609 | $0.00 | $0 | 12,891 | Direct | |
| Aug 10, 2021 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 7,891 | Direct | |
| Aug 11, 2021 | Common Stock | MOption exerciseDisposed | −7,891 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
Referenced by the price of 3 transactions in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $35.50 to 36.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $35.30 to 36.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $34.85 to 35.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.